Please assess the completion status of the following clinical trial:

Trial Title: Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 55\< Age \<70~* Tumor size ≤ 2 cm~* pN0 (SN biopsy or ALND)~* ER/PgR positive~* Margins \> 5 mm (either at initial surgery or at re-excision)~* Clips placed in the surgical bed (minimum of 4 clips)~* Unicentric only~* No lymphovascular invasion~* Any grade~* No extensive intraductal component (\>25%)~* Written informed consent~Exclusion Criteria:~* Prior thoracic radiation therapy~* Oncoplastic surgery / No clips in the surgical bed~* Multicentric cancer~* Autoimmune disease, vasculitis, collagenopathy or scleroderma that may predispose to late sequelae

- Gender: FEMALE
- Minimum Age: 55 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Hypofractionated WBI (Type: ACTIVE_COMPARATOR): Patients treated with hypofractionated Whole Breast Irradiation received Simultaneous Integrated Boost irradiation of the whole breast and surgical bed at two different dose levels using external intensity - modulated radiotherapy (VMAT RA).
- Accelerated Partial Breast Irradiation (Type: EXPERIMENTAL): Patients treated with Accelerated Partial Breast Irradiation received the irradiation on surgical bed using external intensity - modulated radiotherapy (VMAT RA).

Based on this trial design, predict the completion outcome and termination type (if applicable).